World Markets

S.Africa's Adcock Ingram posts higher FY profit, unloads Ghana investment

South African pharmaceutical firm Adcock Ingram Holdings Ltd said on Wednesday full-year earnings rose 10.6% and that it disposed of its investment in Ghana.

JOHANNESBURG, Aug 28 (Reuters) - South African pharmaceutical firm Adcock Ingram Holdings Ltd AIPJ.J said on Wednesday full-year earnings rose 10.6% and that it disposed of its investment in Ghana.

Headline earnings per share from continuing operations for the year ended June 30 rose to 421.7 cents from a restated 381.3 cents in the previous year.

HEPS is the most widely watched profit gauge in South Africa and strips out certain one-off items.

The company said in a statement that it had disposed of its investment in Ayrton Drug Manufacturing Ltd, its associate in Ghana, as its performance did not meet expectations.

Adcock Ingram, which also has operations in India, said revenue rose 11% to 7.1 billion rand ($465.97 million).

($1 = 15.2369 rand)

(Reporting by Nqobile Dludla; Editing by Subhranshu Sahu)

((nqobile.dludla@thomsonreuters.com; +27117753126; Reuters Messaging: nqobile.dludla.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest World Markets Videos

    #TradeTalks: Why now is the case for international markets

    Franklin Templeton Head of Global Index Portfolio Management Dina Ting joins Jill Malandrino on Nasdaq #TradeTalks to discuss why now is the case for international markets and how recent market events have created new opportunities.

    6 days ago

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More